Table 1.
Licensed carbohydrate-based vaccines
Indication | Vaccine | Manufacturer |
---|---|---|
Haemophilus influenzae type b (Hib) | Glycoconjugugate, polysaccharide with TT [ActHIB and Hiberix] | Sanofi Pasteur, SA (ActHIB); GlaxoSmithKline Biologicals, S.A. (Hiberix) |
Diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and Hib-TT conjugate vaccine [Pentacel] | Sanofi Pasteur, Ltd. | |
Hib conjugate (meningococcal protein conjugate) [PedvaxHIB] | Merck & Co, Inc. | |
Hib conjugate (meningococcal protein conjugate) and hepatitis B (recombinant) vaccine [Comvax] | Merck & Co, Inc. | |
| ||
Neisseria meningitides A, C, Y and W-135 | Glycoconjugate, meningococcal polysaccharide with DT [Menactra] | Sanofi Pasteur, Inc. |
Meningococcal polysaccharide [Menomune-A/C/Y/W-135 ] | Sanofi Pasteur, Inc. | |
| ||
Salmonella typhi | Vi polysaccharide [TYPHIM Vi] | Sanofi Pasteur, SA |
| ||
Streptococcus pneumoniae 4, 6B, 9V, 14, 18C, 19F, and 23F | Pneumococcal 7-valent CRM197 conjugate [Prevnar] | Wyeth Pharmaceuticals, Inc. |
Streptococcus pneumoniae 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 23F and 33F | Pneumococcal polysaccharide, 23-valent [Pneumovax 23] | Merck & Co, Inc. |
Note: This table was adapted from the complete list of vaccines licensed for immunization and distribution in the US, found at www.fda.gov.